These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15288486)

  • 1. Prognostic models including the Child-Pugh, MELD and Mayo risk scores--where are we and where should we go?
    Christensen E
    J Hepatol; 2004 Aug; 41(2):344-50. PubMed ID: 15288486
    [No Abstract]   [Full Text] [Related]  

  • 2. Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo End-stage Liver Disease.
    Forman LM; Lucey MR
    Hepatology; 2001 Feb; 33(2):473-5. PubMed ID: 11172352
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis.
    Huo TI; Lin HC; Huo SC; Lee PC; Wu JC; Lee FY; Hou MC; Lee SD
    Liver Transpl; 2008 Jun; 14(6):837-44. PubMed ID: 18508377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of prognosis of patients with decompensated liver cirrhosis using the criterion of the Model of End-Stage Liver Disease].
    Ma H; Wang H; Sun Y; Guo F; Fang JL; Shao J; Rao HY; Wang J; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jun; 13(6):407-9. PubMed ID: 15975270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
    Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
    J Hepatol; 2005 Jun; 42(6):826-32. PubMed ID: 15885353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.
    Wang YW; Huo TI; Yang YY; Hou MC; Lee PC; Lin HC; Lee FY; Chi CW; Lee SD
    J Clin Gastroenterol; 2007 Aug; 41(7):706-12. PubMed ID: 17667056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?
    Giannini E; Botta F; Fumagalli A; Malfatti F; Testa E; Chiarbonello B; Polegato S; Bellotti M; Milazzo S; Borgonovo G; Testa R
    Liver Int; 2004 Oct; 24(5):465-70. PubMed ID: 15482344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit.
    Cholongitas E; Senzolo M; Patch D; Kwong K; Nikolopoulou V; Leandro G; Shaw S; Burroughs AK
    Aliment Pharmacol Ther; 2006 Apr; 23(7):883-93. PubMed ID: 16573791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute-on-chronic hepatitis B liver failure.
    Wang ZX; Yan LN; Wang WT; Xu MQ; Yang JY
    Transplant Proc; 2007 Jun; 39(5):1501-4. PubMed ID: 17580172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
    Fejfar T; Safka V; Hůlek P; Vanásek T; Krajina A; Jirkovský V
    Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis after liver transplantation predicted by preoperative MELD score.
    Kim DJ; Lee SK; Jo JW; Kim SJ; Kwon CH; Park JW; Han YS; Park JB
    Transplant Proc; 2006 Sep; 38(7):2095-6. PubMed ID: 16980010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis.
    Huo TI; Wang YW; Yang YY; Lin HC; Lee PC; Hou MC; Lee FY; Lee SD
    Liver Int; 2007 May; 27(4):498-506. PubMed ID: 17403190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of the model for end-stage liver disease and serum C-reactive protein as prognostic markers in intestinal failure patients on parenteral nutrition.
    Putchakayala K; Polensky S; Fitzhugh J; Cohran V; Buchman A; Fryer J
    JPEN J Parenter Enteral Nutr; 2009; 33(1):55-61. PubMed ID: 18941030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.
    Kim JH; Kim JH; Choi JH; Kim CH; Jung YK; Yim HJ; Yeon JE; Park JJ; Kim JS; Bak YT; Byun KS
    Scand J Gastroenterol; 2009; 44(3):346-57. PubMed ID: 18991165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma.
    Brown DB; Fundakowski CE; Lisker-Melman M; Crippin JS; Pilgram TK; Chapman W; Darcy MD
    J Vasc Interv Radiol; 2004 Nov; 15(11):1209-18. PubMed ID: 15525739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.
    Angermayr B; Luca A; König F; Bertolini G; Ploner M; Gridelli B; Ulbrich G; Reiberger T; Bosch J; Peck-Radosavljevic M
    Eur J Clin Invest; 2009 Jan; 39(1):65-71. PubMed ID: 19087131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prediction of perioperative mortality in patients with advanced liver disease and abdominal surgery by the use of different scoring systems and tests].
    Hofmann WP; Rädle J; Moench C; Bechstein W; Zeuzem S
    Z Gastroenterol; 2008 Nov; 46(11):1283-9. PubMed ID: 19012201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are physician-derived disease severity indices associated with health-related quality of life in patients with end-stage liver disease?
    Kanwal F; Hays RD; Kilbourne AM; Dulai GS; Gralnek IM
    Am J Gastroenterol; 2004 Sep; 99(9):1726-32. PubMed ID: 15330910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis.
    Huo TI; Lin HC; Wu JC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
    Liver Transpl; 2006 Jan; 12(1):65-71. PubMed ID: 16382473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application of Model for end-stage liver disease to predict the prognosis of and curative effect for chronic severe hepatitis].
    Liu Q; Liu Z; Wang TL; Zhang LL
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(25):1773-7. PubMed ID: 16253168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.